Finland’s Future Home for Evidence-Based Peptide Information
We’re building Finland’s most comprehensive independent resource on peptides, GLP-1 medications, and metabolic health — clear, research-driven, and free from commercial bias.
What’s Coming
Peptide.fi brings together well-researched information on peptides and metabolic health — all in one place, explained clearly.
Evidence-based articles
Research-driven content, without the marketing language.
GLP-1 guides
Semaglutide, tirzepatide, and retatrutide explained in plain language.
Peptide library
A comprehensive directory of common peptides and their uses.
Latest research
We follow the field’s research and summarize what matters most.
Practical health guides
Concrete information on metabolic health and recovery.
Comparison tools
Tools to compare different options and approaches.
Finnish & English
Content in two languages for wider accessibility.
Why Peptide.fi
Independent
We don’t sell products or represent a single clinic or brand.
Research-focused
Every claim is grounded in an identifiable source, not assumptions.
Understandable language
Complex science explained without unnecessary jargon.
Constantly updated
Content is reviewed and updated as research evolves.
Transparent sources
References and sources are visible, not buried in footnotes.
Be the First to Know
Leave your email and we’ll notify you the moment Peptide.fi launches. No spam — just the launch announcement.
We respect your privacy. You can unsubscribe at any time.
Frequently Asked Questions
When will the website launch?
We’re aiming to launch during 2026. Waiting list subscribers will be the first to know.
Will the information be free?
Yes. The core content is open and free for everyone.
Will there be content in English?
Yes, most of the content will be published in both Finnish and English.
Will you review new medications?
We follow new research and medications, such as GLP-1 treatments, and update our content accordingly.
Is Peptide.fi affiliated with any clinic or manufacturer?
No. We operate as an independent information resource with no commercial ties.